Study on the safety of compound cortex FUFANGHUANGBAI liquid paint in clinical use

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200066651

Enrollment

Unknown

Registered

2022-12-13

Start date

2022-04-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open ended

Interventions

Case series:no

Eligibility

Sex/Gender

All

Age

No minimum to 89 Years

Inclusion criteria

Inclusion criteria: (1) the patients who were treated by compound huangbaiye paint; (2) the patients voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: NO Exclusion

Design outcomes

Primary

Measure	Time frame
Safety observation;	—

Countries

China

Contacts

Public ContactFengchuan Zhang

Beijing University of Chinese Medicine Oriental Hospital

bjzfc@sina.com13901103592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026